Week of 9/16/2024: June 27, 2024: "SMC will be
Post# of 148110
(Total Views: 537)
Posted On: 09/08/2024 11:22:47 PM
Week of 9/16/2024:
June 27, 2024:
"SMC will be conducting a twelve-week preclinical mouse study evaluating both 350 and 700 mg dose levels"
Imagine won't take SMC long to compile the data, being no Safety Board or FDA input.
12 weeks is 9/20/2024.
___________
August 12, 2024:
microsatellite stable (MSS), relapsed or refractory metastatic colorectal cancer (mCRC).
"The Company intends to proceed with a submission of its final study protocol to the FDA"
If submitted 1 week later, & FDA replies within 30 days:
9/16/2024.
June 27, 2024:
"SMC will be conducting a twelve-week preclinical mouse study evaluating both 350 and 700 mg dose levels"
Imagine won't take SMC long to compile the data, being no Safety Board or FDA input.
12 weeks is 9/20/2024.
___________
August 12, 2024:
microsatellite stable (MSS), relapsed or refractory metastatic colorectal cancer (mCRC).
"The Company intends to proceed with a submission of its final study protocol to the FDA"
If submitted 1 week later, & FDA replies within 30 days:
9/16/2024.
(7)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼